LINCOLN PHARMACEUTICALS LTD. - Board recommends Dividend

	< Back
30 May 2015
Lincoln Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has:<BR><BR>1. Recommended dividend of Re. 1.00(10%) per Equity Share of face value Rs. 10/- each.<BR><BR>2. Allotted 36,89,200 warrants convertible in to equal number of Equity shares on preferential basis to the promoters / promoters' group and persons other than the promoters / promoters group pursuant to the Securities And Exchange Board of India (Issue Of Capital And Disclosure Requirements) Regulations, 2009.<BR><BR>3. Approved and adopted the Code of Conduct for prohibition of Insider Trading as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
View all announcements for LINCOLN PHARMACEUTICALS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us